Gildan (GIL) Q1 2026 Earnings Call Transcript

Gildan reported Q1 revenue of $1.17 billion, up 63.8% year over year, with adjusted gross margin improving to 33.0% from 31.2% despite adjusted EPS declining to $0.43 from $0.59. Management reaffirmed 2026 guidance for $6.0 billion-$6.2 billion revenue, ~20% adjusted operating margin, $4.20-$4.40 adjusted EPS, and more than $850 million in free cash flow, while targeting $250 million of run-rate synergies over three years. The quarter was mixed because acquisition benefits and share gains were offset by integration costs, higher interest expense, and inventory reduction headwinds, but the company said Bangladesh operations remain normal and buybacks should resume once leverage returns toward 2x.

Analysis

The core read-through is not the reported quarter itself, but the setup for the next two quarters: management is intentionally suppressing sell-in to accelerate channel normalization and integration, which means near-term reported revenue can stay noisy even as underlying share gains improve. That creates a valuation trap for momentum buyers but a potentially attractive entry point for investors who can underwrite a H2 inflection, because the earnings power is being pulled forward into 2027 via synergy realization, not just compressed into 2026 optics.

The bigger second-order effect is competitive: by moving Hanes production into Gildan’s lower-cost network, the company is effectively converting a legacy branded retail asset into a manufacturing and sourcing arbitrage story. That should pressure smaller apparel suppliers and private-label competitors that lack the scale to hedge input costs, absorb SG&A, and still fund innovation. It also raises the odds that premium product mix continues to outgrow the category even if end-market unit growth stays flat, which is the mechanism behind margin resilience here.

The market seems to be underestimating balance-sheet optionality. At 3.3x leverage and negative FCF this quarter, the stock is being priced as if deleveraging is a multi-year slog; but if the divestiture process closes and free cash flow ramps toward the guided $850M+, buybacks can re-enter much sooner than the street likely models. The main tail risk is geopolitical disruption to Bangladesh or a sudden consumer pullback, but the company’s visible hedging and redundancy reduce the probability that either becomes a 2026 earnings reset rather than a timing issue.

Key Decisions for Investors

• Go long GIL on a 3-6 month horizon on any post-earnings weakness; the setup is for a H2 revenue re-acceleration plus margin expansion as inventory normalization ends and synergies flow through. Risk/reward is favorable if you believe 2027 EPS power is being discounted at a 2026 trough multiple.
• Pair long GIL / short a diversified apparel or basic-consumer supplier basket over the next 2-4 months; GIL has a clearer self-help catalyst stack, while peers are more exposed to demand softness and lack comparable synergy-driven upside.
• Buy GIL call spreads or risk reversals into the next 1-2 quarters if implied volatility is elevated but not extreme; the convexity comes from a potential leverage-and-buyback re-rating once HAA proceeds are visible and H2 growth returns.
• Avoid shorting HBI as a standalone event-driven trade unless you can stomach timing risk; the more durable short is competitors reliant on legacy underwear/basic apparel share, because GIL’s innovation and distribution integration should pressure category margins over 2027.
• Set a tactical exit/reduce alert if Bangladesh disruption headlines intensify or if working-capital normalization slips beyond Q2; those are the two signals most likely to break the H2 inflection thesis before the market gives credit.